Sunlight Exposure and Breast Cancer Risk: A Systematic Review and Meta-analysis.

Cancer Epidemiol Biomarkers PrevNov 2, 2026

Fausto Petrelli, Antonio Ghidini, Karen Borgonovo et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and random-effects meta-analysis combined 31 epidemiologic studies to assess sunlight exposure and breast cancer incidence, subtype, and survival. Higher exposure was associated with lower overall incidence (pooled OR, 0.80; 95% CI, 0.74-0.86). Associations were strongest in case-control studies using personal exposure measures and weaker in cohorts using ambient ultraviolet proxies. Lower risk was observed for ER-negative and triple-negative tumors, but not ER-positive disease. Diagnoses in sunnier seasons were also associated with improved survival. The authors characterize the findings as hypothesis-generating given observational evidence and potential confounding and exposure misclassification.

Key findings

  • Higher sunlight exposure was associated with lower breast cancer incidence (pooled OR, 0.80; 95% CI, 0.74-0.86).
  • Associations were present for ER-negative tumors (OR, 0.71; 95% CI, 0.58-0.87) and triple-negative tumors (OR, 0.55; 95% CI, 0.37-0.81), but not ER-positive disease.
  • Breast cancer diagnoses in sunnier seasons were associated with improved survival (hazard ratio, 0.84; 95% CI, 0.80-0.88).
  • Dose-response analysis indicated an 8% lower risk per 10 relative exposure units.

Why it matters

The subtype-specific associations suggest that sunlight exposure may relate differently to breast cancer biology across receptor groups, while the survival finding raises a separate question about seasonal light exposure. These results may help guide research into environmental influences on breast cancer, but they do not establish that sunlight itself reduces risk; any consideration of exposure must also account for skin cancer risk.

What to keep in mind

The evidence is observational and subject to confounding and exposure misclassification; exposure measures also differed across study designs.

Source

Published in Cancer Epidemiol Biomarkers Prev. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.